Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Wino115


T.TH

RE:Oh well fun is over

Honestly, we knew a correction would have to come given the absolutely...

September 12, 2023

T.TH

Any thoughts?

Why has it taken longer than it should to find Patient #1 for the P1 trial...

September 11, 2023

T.TH

RE:RE:RE:RE:RE:RE:RE:Well?

A more accurate term would be a bounce from massively oversold and...

September 8, 2023

T.TH

RE:RE:RE:RE:RE:RE:Well?

Value triggers were pretty compelling at that bottom - market cap a fraction...

September 8, 2023

T.TH

RE:RE:RE:RE:RE:RE:ATM used?

Good working Capital mgmt is ok. Although hard to repeat but maybe they are...

September 5, 2023

T.TH

RE:RE:RE:Good news for me

Nothing should be done until we see results on new trial.  That's...

September 5, 2023

T.TH

ATM used?

Anyone think the selling volume is actually company selling the ATM shares...

September 5, 2023

T.TH

RE:Good news for me

Nice you now have at least two medicines to treat your cancer. The pace of...

September 5, 2023

T.TH

RE:RE:One thing shareholders wanted

I'd say they didn't quite have enough start-up/biotech RD types on...

July 21, 2023

T.TH

One thing shareholders wanted

At least they're responding to shareholders. Littlejohn had lowest votes...

July 21, 2023

T.TH

RE:Wino is MIA?

Thanks for checking in, all is fine and just enjoying the summer.  I am...

July 19, 2023

T.TH

RE:RE:RE:RE:Combo tests with anti PD-L1 chekpoint inhibitors

Interesting thoughts, indeed.  I've also thought that it doesn't...

June 16, 2023

T.TH

RE:RE:RE:Shure hope they avoid another OO at these levels

This really is the case as far as raising money. I guess I would hope that if...

June 15, 2023

T.TH

RE:Shure hope they avoid another OO at these levels

Let's poll folks.  At what price and amount would you be ok with...

June 14, 2023

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:Rebranding the Sort1

It's definitely trickier with small sample sizes. But I also figure they&...

June 14, 2023

T.TH

RE:RE:RE:RE:RE:Rebranding the Sort1

The high grade serous subtype may be higher and that is what they are...

June 14, 2023

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Very encouraging, but approval will take time

It sounded somewhat along these lines from putting together a few of the...

June 13, 2023

T.TH

Investigators, very helpful - lots to digest

Having the KOLs was highly beneficial --realistic, reminder of clinical...

June 13, 2023

T.TH

RE:RE:New Press Release - Theratechnologies June 13 Oncology Investigator Call to Update Investors & Analysts on Phase 1 Sudocetaxel Zendusortide Trial

I noticed in their AACR photos you had both Sharma and FM-B there. I would...

June 12, 2023

T.TH

RE:RE:Theratechnologies is a triple from here, says Leede Jones Ga

I may be wrong since I haven't actually seen his report, but he may be...

June 7, 2023

Featured Company